Callicutt Jack W

Avg. Two Year Performance

(42%) Avg. Purchase Return
(19%) Compound
61% Avg. Sale Return
27% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return9%(< 1%)(12%)(33%)(42%)
Purchase Success Rate3 of 42 of 41 of 40 of 40 of 4
Average Sale Return17%22%33%45%61%
Sale Success Rate2 of 21 of 21 of 22 of 22 of 2

VIA Pharmaceuticals, Inc.

Drugs » Biotechnology

VP-Finance&Admin, Chf Acct Off:

Holdings: 1.0K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Pro-Pharmaceuticals Inc.

Drugs » Drugs - Generic

Chief Financial Officer:

Holdings: 7.61K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Vystar Corp

Other » Other

chief financial officer:

Holdings: shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--